Kotak Mahindra Life Insurance bought 24 lakh shares of Thyrocare Technologies for ₹149.76 Cr at ₹624.00 apiece in a block deal. This occurred as promoter Docon Technologies sold a 9.90% stake, reducing their holding from 60.92% to 51.02%.
A healthcare diagnostics provider, Thyrocare Technologies operates a network of diagnostic centers across India delivering laboratory testing and pathology services. The company partners with hospitals, clinics, and independent laboratories to offer affordable diagnostic solutions to patients nationwide. Its distinctive approach combines technology-enabled operations with cost-effective service delivery, making quality diagnostic care accessible across urban and semi-urban markets in India.
Wholly owned subsidiary of Kotak Mahindra Bank. Crossed Rs 1 lakh crore in AUM in November 2025, the 25th year of operations, with a 19% CAGR since 2010. CIO Radhavi Deshpande joined from Kotak Mahindra Bank's proprietary trading desk in April 2021 and runs a disciplined large and midcap equity book.
